[628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY - Peck-Radosavljevic, M.; Boletis, J.; Besisik, F.; Lucia Ferra, M.; Alric, L.; Samuel, D.; Messinger, D.; Junker, H.; Cheinquer, H. (Journal of Hepatology, 2007)